Air fairing for frameless trailer

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Mac Trailer Manufacturing, Inc. patent solves the following problem:

The present invention relates generally to systems and devices that increase aerodynamic efficiency. Particularly, the invention relates generally to a wind fairing or trailer skirts on trailers. In particular, the invention relates to an air fairing for a frameless trailer.

Our analysis of this patent is as follows:

Mac Trailer Manufacturing, Inc.’s patent US 9283998 B2 deals with Air fairing for frameless trailer.
An air fairing device connected to the bottom under a frameless trailer improve flight efficiency and improve fuel economy. A picture of the wind fairing device provides a wind deflector position ahead of a trolley that supports the frameless trailer on a back end. The second image in the air fairing device provides two things mounted under the frameless trailer. The first deflector is attached and handed down from one sustain arm, said arm connecting the trailer of a semi-tractor or truck. The second deflector connected below the bottom of the frameless trailer and positioned behind the first deflector and the side of the trolley. A third image is similar to the second, but further includes a third deflector positioned between the two axles of the trolley.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Merck Sharp & Dohme Corp. patent solves the following problem:

Spleen Tyrosine Kinase (SYK) is a protein tyrosine kinase described as a key mediator of immunoreceptor signaling a host of inflammatory cells including mast cells, B-cells, macrophages and neutrophils. These immunoreceptors, including Fc receptor and the B-cell receptor, is important for allergic diseases, and antibody-mediated autoimmune diseases and thus pharmacologically interfering SYK conceivably treat these diseases.

Our analysis of this patent is as follows:

Merck Sharp & Dohme Corp.’s patent US 9006444 B2 deals with Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors.
invention provides certain phenyl formamide-containing compounds of Formula (I); or pharmaceutically acceptable salts thereof, wherein A and B as described here. invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated spleen tyrosine kinase (SYK) kinase.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Synbiotic mixture

File for Quick & Easy Patent Protection with PowerPatent.

The Nestec S.A. patent solves the following problem:

The human colon colony in a wide range of bacteria that have both positive and negative effects on gut physiology as well as having other systemic influences. Predominant group of bacteria found in the colon include Bacteroides, bifidobacteria, eubacteria, clostridia and lactobacilli. The bacteria present have fluctuating activities in response to substrate availability, redox potential, pH, O2 tension and distribution in the colon. In general intestinal bacteria can be divided into species that could potentially exert any harmful or beneficial effects on the host. Pathogenic effects (which can cause clostridia or Bacteroides, for example) include diarrhea, infections, liver damage, carcinogenesis and intestinal corruption. Health-promoting effects may be due to inhibition of growth and colonization of harmful bacteria, stimulation of immune functions, improve digestion and absorption of essential nutrients and synthesis of vitamins. An increase in the number and / or activity of bacteria in the genus Bifidobacterium and Lactobacillus that have health promoting properties is desirable.

Our analysis of this patent is as follows:

Nestec S.A.’s patent US 9005682 B2 deals with Synbiotic mixture.
This invention relates to a preparation containing a probiotic bacterial strain and a prebiotic mixture comprising 5-70 wt% of at least one N-acetylated oligosaccharide selected from the group consisting Ga1NAc1,3Ga11,4G1c and Ga11,6Ga1NAc1,3Ga11,4G1c, 20- 95 wt% of at least one neutral oligosaccharide selected from the group consisting Ga11,6Ga1, Ga11,6Ga11,4G1c Ga11,6Ga11,6G1c, Ga11,3Ga11,3G1c, Ga11 3Ga11,4G1c, Ga1 1,6Ga1 1,6Ga1 1, 4GIc, Ga1 1,6Ga1 1,3Ga1 1,4GIc Ga1 1,3Ga1 1,6Ga1 1,4GIc and Ga11,3Ga11,3Ga11,4G1c and 2-50 wt% at least one sialylated oligosaccharide selected from the group consisting NeuAc2,3Ga11, 4G1c and NeuAc2,6Ga11,4G1c. The invention is given to food products comprising said preparation and use in preparation for the prevention and treatment of infections.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

BTL-II nucleic acids

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Immunex Corporation patent solves the following problem:

Modulation of an immune or inflammatory response can be a valuable tool to control various types of diseases including autoimmune diseases, diseases characterized by abnormal inflammation and / or immune response, and infections . In treating diseases characterized by abnormal inflammation and / or immune responses, such as inflammatory bowel disease and autoimmune or inflammatory diseases, modulation of an immune response is desirable. In other situations, for example when the vaccine to a patient to give immunity to an infectious disease, stimulation of an immune response is desirable. In the case of vaccines, adjuvants on an immune response to a coadministered antigen can be valuable in providing long term protection against the disease. Particularly lacking in the art is the adjuvants capable of stimulating a mucosal immune response. A mucosal immune response, as opposed to a systemic immune response, is valuable because it attacks an infection with a very common point of entry, that is, to a mucosal surface. The present invention addresses these needs in the art by providing therapeutic agents for the diagnosis and treatment of diseases characterized by inadequate and / or abnormal inflammation and / or immune response and therapeutic agents that act as adjuvants to stimulate an immune response, particularly a mucosal immune response.

Our analysis of this patent is as follows:

Immunex Corporation’s patent US 7709618 B2 deals with BTL-II nucleic acids.
invention provides isolated BTL-II protein, nucleic acid, antibody, enemies, and agonists and methods of making and using the same. Diagnostic, screening, and therapeutic methods of using the compositions of the invention given. For example, the composition of the invention can be used for diagnosis and treatment of inflammatory intestinal diseases and for the development of a mucosal immune response to an antigen.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Treatment of infection in animals

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Mars, Inc. patent solves the following problem:

This application is the US National Stage of International Application No. PCT / GB01 / 01036, filed on March 9, 2001. This application further claims foreign priority PCT / Mb00 / 00890 filed on March 10, 2000, United Kingdom Using 0012401.6 filed May 22, 2000, and United Kingdom Using 0022210.9 filed on Aug. 11, 2000.

Our analysis of this patent is as follows:

Mars, Inc.’s patent US 7608291 B2 deals with Treatment of infection in animals.
The present invention relates to the use of a non-digestible carbohydrate in the form of a composition for treating or preventing pathogenic bacteria in the large intestine of a pet. It also provides a method for the prevention or treatment of a pathogenic bacteria in the large intestine of a pet, the method comprising administering said pet animal a composition comprising a non- digestible carbohydrate.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Information recording/displaying card

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Minolta Co., Ltd. patent solves the following problem:

The present invention relates to an information recording / display card. Particularly, it relates to an information recording / display card containing an invisible information recording part and a visible information display part information written under predetermined heating conditions and written information can be erased, and an information recording / display system using the card.

Our analysis of this patent is as follows:

Minolta Co., Ltd.’s patent US 6580481 B2 deals with Information recording/displaying card.
the invention provides an information recording / displaying card information and a recording / display system using cards that invisible information will be recorded, so that the information can be displayed as view information and see information can be written / erased as color images in a practical speed. The information recording / display card includes a visible display of information and an invisible information recording part. These parts would, for example, the front and back of the card, respectively, or arranged side by side in the front or the back face. The visible information display part includes, as a main part, a low molecular weight cholesteric liquid crystal compound having an isotropic phase transition temperature higher than a melting point, such information will be shown, once written and laid therein. The invisible information recording part, for example, a magnetic recording layer, a write-once optical recording layer of an integrated circuit memory, information can be recorded and erased.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.